GoodRx Business Model Canvas

Affiliations with licensed clinicians and GoodRx’s HeyDoctor network (acquired 2018) expand virtual care breadth, supporting both asynchronous e-visits and synchronous video/phone consultations for common conditions. Credentialing, scheduling, and standardized quality protocols ensure compliant, state-licensed care delivery. Revenue-sharing arrangements and tracked referral flows align provider and platform incentives and drive utilization.

Network of 70,000+ U.S. pharmacies ensures wide coupon acceptance and POS redemption.

Top three PBMs handle ~80% of claims, supplying negotiated pricing, BIN/PCN routing and rebate flows.

Pharma partners drive copay offers and targeted DTC spend (~8 billion 2023–24); HeyDoctor/clinicians expand telehealth services.

SEO, SEM and pharmacy/insurer partnerships drive app installs and web traffic, supporting tens of millions of monthly users in 2024. CRM, push notifications and refill reminders raise repeat usage and adherence, with reminders shown to boost refills by ~20% in real-world studies. Systematic A/B testing improves landing-page and conversion rates (typical lifts 10–30%). Loyalty programs (points/coupons) increase long-term engagement and lifetime value.

Collecting and normalizing pharmacy price feeds, generating redeemable coupon codes and routing BIN/PCN for checkout, and operating telehealth with e-prescribing are core activities that enable savings and end-to-end prescription fulfillment. Continuous monitoring, adjudication analysis and partner integrations sustain accuracy and acceptance. Compliance (HIPAA, state telehealth rules) and security operations mitigate legal risk.

Mobile, web and backend services orchestrate search, coupon delivery and integrated telehealth workflows, serving millions of monthly users via unified stacks. APIs connect to PBMs and the US retail network of about 67,000 pharmacies and major PBMs covering roughly 80% of insured lives. Architected for horizontal scaling to absorb multi-fold traffic spikes during promotional campaigns. End-to-end security uses HIPAA controls, SOC 2 frameworks and encryption in transit and at rest.

GoodRx key resources include a proprietary price repository covering ~88,000 US pharmacy locations and acceptance at >70,000 stores, 20M MAU (2024) and historical transaction data enabling personalized savings, licensed clinicians and telehealth e‑prescribe integration, plus PBM contracts covering ~80% of insured lives and SOC2/HIPAA security.

On-demand virtual visits treat common conditions affordably through GoodRx Care (GoodRx acquired telehealth provider HeyDoctor in 2018), reducing barriers to primary care. Integrated e-prescribing streamlines care-to-pharmacy workflows and supports rapid medication fulfillment. Visits feature upfront, competitive pricing and extended availability, including evenings and weekends, supporting elevated telehealth use that remains above pre-2020 baselines per CDC reporting.

Instant discounts that often beat cash prices saved consumers >$35B since 2011 (as of 2024), reducing abandonment and improving adherence. Transparent, side-by-side pricing and geolocated results serve >20M monthly users (2024) across a 70,000+ pharmacy network. Integrated telehealth, e-prescribing, alerts and paid memberships deliver faster care, higher fulfillment and deeper negotiated savings.

Customer support via help centers, chat, and phone resolves redemption issues and liaises with pharmacies to ensure valid coupons are honored; GoodRx reported over 20 million monthly active users in 2023, underscoring scale for support demand. FAQs and scripted checkout dialogs prepare users for pharmacy conversations and reduce friction. Rapid response preserves trust and lowers churn.

GoodRx maintains low-touch, self-service relationships with 20 million monthly active users in 2024, driving scale and low support costs; in-app telehealth and saved profiles increase conversions. Multichannel messaging (SMS ~98% open, email ~20–25%) and price-change/refill nudges (up to ~20% lift) boost adherence and repeat use. Premium tiers and family plans (3 million paid members at end-2023; $1.06B revenue in 2023) raise ARPU and retention.

Lifecycle communications via Email, SMS, and Push drive retention for GoodRx, which served about 20 million monthly active users in 2024; coordinated touchpoints reduce churn by keeping users engaged. Refill reminders and real-time price alerts are timely, leveraging SMS open rates near 98% and push click-throughs around 7–10% to prompt action. Segmentation tailors messaging to behavior and Rx history, improving relevance and conversion. Compliance enforces consent and easy opt-out to meet TCPA and CAN-SPAM requirements.

Mobile app (20M+ monthly) and website (70M annual visits) drive search-to-coupon conversions; GoodRx+ and telehealth monetize in‑app payments supporting $1B revenue (2023). Email/SMS/Push (SMS opens ~98%; push CTR 7–10%) plus refill alerts lift retention. POS code scans at ~61,000 pharmacies validate savings via APIs; partners (employers, payers, affiliates) and paid/social lower CAC.

Chronic condition patients—about 6 in 10 US adults have at least one chronic disease and roughly 4 in 10 have two or more (CDC)—need consistent, low prices to maintain long-term therapy. Persistent savings through GoodRx discounting reduce cost-related nonadherence, which affects about 1 in 4 adults (KFF). Refill reminders and stable pharmacy selection support continuity, while telehealth eases routine renewals and monitoring.

Uninsured/underinsured (~8.8% US, 2023) and high-deductible members (~33% insured, 2024) seek immediate point-of-sale savings; chronic patients (≈60% adults; ≈40% multimorbidity) need consistent low prices to improve ~50% adherence; employers (≈150M covered, 2024) and telehealth users value cost reduction, upfront pricing, and e-prescribe convenience.

Redemption QA, customer service, and pharmacy relations are core operational costs driving SG&A for GoodRx; in 2023 GoodRx reported roughly $1.1 billion in revenue, underlining scale-based support needs. Content production and localization add overhead across platforms and markets, often representing a mid-single-digit percent of marketing spend. Payment processing fees typically range 2–3% per visit or membership transaction, and partner management requires dedicated account teams to maintain pharmacy and PBM relationships.

Core costs: cloud/CDN and engineering drove higher unit costs as enterprise cloud spend rose ~20% in 2024; GoodRx reported ~$1.1B revenue in 2023. Marketing, affiliates and CAC remain material; payment fees ~2–3% per transaction. Clinical/telehealth costs include clinician pay $30–80/visit and malpractice $7k–20k/yr. Compliance and breach risk add outsized overhead (IBM 2023 avg breach cost $4.45M).

Users pay per consult for virtual care, with tiered pricing commonly ranging from $20–$100 per visit in 2024 depending on condition and service level. Efficient, standardized workflows and nurse triage protect margins by reducing clinician time per consult. Bundling consults with prescription discounts increases conversion and uptake in GoodRx’s platform.

GoodRx earns per-script fees (~$0.50–$3.00) on redeemed coupons, leveraging ~4.3B US scripts (2023) and scale to grow top line. GoodRx+ subscription and family plans raise ARPU against a >$400B US retail Rx market (2024). Virtual care visits ($20–$100/visit in 2024) and targeted pharma media (US pharma digital spend ~$7.5B; ads ~15–25% of ecosystem revenue) diversify revenue. De-identified analytics sell to partners under strict privacy controls.